FIELD: medicine.
SUBSTANCE: invention relates to the use of leucine, acetyl-leucine or their pharmaceutically acceptable salts for the treatment of a restless leg syndrome.
EFFECT: obtaining therapeutic agents for the treatment of neurodegenerative diseases.
11 cl, 14 dwg, 35 tbl, 22 ex
| Title |
Year |
Author |
Number |
| THERAPEUTIC AGENTS AGAINST NEURODEGENERATIVE DISEASES |
2017 |
|
RU2756519C2 |
| PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS AGAINST LYSOSOMAL STORAGE DISEASES |
2017 |
|
RU2749515C2 |
| DEUTERATED ANALOGUES OF ACETYLEUCINE |
2019 |
|
RU2810793C2 |
| LEUCINE, ACETYLLECINE AND RELATED ANALOGUES FOR TREATMENT OF DISEASE |
2020 |
- Factor, Mallory
- Fields, Taylor
|
RU2815373C2 |
| THERAPEUTIC AGENTS FOR THE TREATMENT OF RESTLESS LEG SYNDROME |
2019 |
- Factor, Mallory
- Strupp, Michael
|
RU2802288C2 |
| ACETYL LEUCINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR IMPROVING THE MOTOR FUNCTION AND THE COGNITIVE FUNCTION |
2017 |
- Fektor, Mellori
- Shtrup, Mikhael
|
RU2745912C2 |
| ACETYLEUCINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR IMPROVING MOTOR FUNCTION AND COGNITIVE FUNCTION |
2021 |
- Factor, Mallory
- Strupp, Michael
|
RU2837641C2 |
| TREATMENT OF MIGRAINE |
2018 |
- Strupp, Michael
- Factor, Mallory
|
RU2772278C2 |
| COMBINATION OF ACETYLLEICINE FOR TREATMENT OF DIZZINESS |
2017 |
- Syrov Kirill Konstantinovich
- Nesteruk Vladimir Viktorovich
- Zamergrad Maksim Valerevich
|
RU2680413C1 |
| DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS |
2005 |
|
RU2394570C2 |
